Loading…

Augmentation of central arterial pressure in mild primary hyperparathyroidism

Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular risk, although the mechanisms involved remain unclear. Recent evidence has shown increased pulse pressure to be a powerful predictor of cardiovascular events. As increases in pulse pressure are due largely to arterial sti...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2000-10, Vol.85 (10), p.3515-3519
Main Authors: SMITH, J. C, PAGE, M. D, JOHN, R, WHEELER, M. H, COCKCROFT, J. R, SCANLON, M. F, DAVIES, J. S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c251t-9dc75e0316f986a687f408d3d75831091827df937fbe0cb05b1ba26a14ec0fe33
cites
container_end_page 3519
container_issue 10
container_start_page 3515
container_title The journal of clinical endocrinology and metabolism
container_volume 85
creator SMITH, J. C
PAGE, M. D
JOHN, R
WHEELER, M. H
COCKCROFT, J. R
SCANLON, M. F
DAVIES, J. S
description Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular risk, although the mechanisms involved remain unclear. Recent evidence has shown increased pulse pressure to be a powerful predictor of cardiovascular events. As increases in pulse pressure are due largely to arterial stiffening, we measured arterial stiffness in 21 subjects with PHPT (18 women and 3 men; 46-71 yr old) and 21 age- and sex-matched healthy controls using pulse wave analysis, a technique that measures peripheral arterial pressure waveforms and generates corresponding central aortic waveforms. This allows determination of the augmentation of central pressure resulting from wave reflection and augmentation index, a measure of vessel stiffness. Metabolic parameters were also measured. The serum calcium level among PHPT subjects was (mean +/- SD) 2.74+/-0.14 mmol/L. pulse wave analysis showed that both augmentation and the augmentation index were significantly higher in the PHPT group vs. controls [16+/-5 vs. 10+/-4 mm Hg (P < 0.001) and 36+/-9% vs. 25+/-6% (P < 0.001)] despite comparable brachial systolic pressures between groups (136+/-13 vs. 134+/-18 mm Hg). Patients with PHPT had higher fasting serum insulin levels [median (range), 15.8 (7.4-39.4) vs. 11.6 (5.1-23) mU/L; P < 0.05] and triglyceride (1.6+/-0.6 vs. 1.2+/-0.4 mmol/L; P < 0.05), but lower high density lipoprotein cholesterol (1.4+/-0.4 vs. 1.6+/-0.3 mmol/L; P < 0.05). These data indicate that subjects with mild PHPT (calcium,
doi_str_mv 10.1210/jc.85.10.3515
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72382461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72382461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c251t-9dc75e0316f986a687f408d3d75831091827df937fbe0cb05b1ba26a14ec0fe33</originalsourceid><addsrcrecordid>eNpF0EtLxDAQB_AgiruuHr1KD-KtayaPJjkuiy9Y8aLgraR5uFn6MmkP--0tWPE08x9-DMMgdA14DQTw_cGsJV9PiXLgJ2gJivFcgBKnaIkxgVwJ8rlAFykdMAbGOD1HCwBcAFN0iV4341fj2kEPoWuzzmdmClHXmY6Di2Fq-uhSGqPLQps1obbTIDQ6HrP9sXex11EP-2Psgg2puURnXtfJXc11hT4eH963z_nu7ellu9nlhnAYcmWN4A5TKLyShS6k8AxLS63gkgJWIImwXlHhK4dNhXkFlSaFBuYM9o7SFbr73dvH7nt0aSibkIyra926bkylIFQSVsAEb2Y4Vo2z5Xx7-feACdzOQCejax91a0L6d5wUUgH9AZpdalo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72382461</pqid></control><display><type>article</type><title>Augmentation of central arterial pressure in mild primary hyperparathyroidism</title><source>Oxford Journals Online</source><creator>SMITH, J. C ; PAGE, M. D ; JOHN, R ; WHEELER, M. H ; COCKCROFT, J. R ; SCANLON, M. F ; DAVIES, J. S</creator><creatorcontrib>SMITH, J. C ; PAGE, M. D ; JOHN, R ; WHEELER, M. H ; COCKCROFT, J. R ; SCANLON, M. F ; DAVIES, J. S</creatorcontrib><description><![CDATA[Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular risk, although the mechanisms involved remain unclear. Recent evidence has shown increased pulse pressure to be a powerful predictor of cardiovascular events. As increases in pulse pressure are due largely to arterial stiffening, we measured arterial stiffness in 21 subjects with PHPT (18 women and 3 men; 46-71 yr old) and 21 age- and sex-matched healthy controls using pulse wave analysis, a technique that measures peripheral arterial pressure waveforms and generates corresponding central aortic waveforms. This allows determination of the augmentation of central pressure resulting from wave reflection and augmentation index, a measure of vessel stiffness. Metabolic parameters were also measured. The serum calcium level among PHPT subjects was (mean +/- SD) 2.74+/-0.14 mmol/L. pulse wave analysis showed that both augmentation and the augmentation index were significantly higher in the PHPT group vs. controls [16+/-5 vs. 10+/-4 mm Hg (P < 0.001) and 36+/-9% vs. 25+/-6% (P < 0.001)] despite comparable brachial systolic pressures between groups (136+/-13 vs. 134+/-18 mm Hg). Patients with PHPT had higher fasting serum insulin levels [median (range), 15.8 (7.4-39.4) vs. 11.6 (5.1-23) mU/L; P < 0.05] and triglyceride (1.6+/-0.6 vs. 1.2+/-0.4 mmol/L; P < 0.05), but lower high density lipoprotein cholesterol (1.4+/-0.4 vs. 1.6+/-0.3 mmol/L; P < 0.05). These data indicate that subjects with mild PHPT (calcium, <3.0 mmol/L) have increased arterial stiffness, as evidenced by higher augmentation of central aortic pressures. Enhanced vessel stiffness may arise from a combination of structural and functional vascular changes due to hypercalcemia and/or metabolic abnormalities. Increased vascular stiffness in subjects with PHPT may account in part for the increased cardiovascular risk in this group.]]></description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.85.10.3515</identifier><identifier>PMID: 11061493</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Aged ; Aging - physiology ; Arteries - pathology ; Biological and medical sciences ; Blood Glucose - metabolism ; Blood Pressure - physiology ; Calcium - blood ; Endocrinopathies ; Female ; Humans ; Hyperparathyroidism - pathology ; Hyperparathyroidism - physiopathology ; Lipids - blood ; Male ; Medical sciences ; Middle Aged ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Parathyroid Hormone - blood ; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) ; Risk Factors</subject><ispartof>The journal of clinical endocrinology and metabolism, 2000-10, Vol.85 (10), p.3515-3519</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c251t-9dc75e0316f986a687f408d3d75831091827df937fbe0cb05b1ba26a14ec0fe33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1526891$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11061493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SMITH, J. C</creatorcontrib><creatorcontrib>PAGE, M. D</creatorcontrib><creatorcontrib>JOHN, R</creatorcontrib><creatorcontrib>WHEELER, M. H</creatorcontrib><creatorcontrib>COCKCROFT, J. R</creatorcontrib><creatorcontrib>SCANLON, M. F</creatorcontrib><creatorcontrib>DAVIES, J. S</creatorcontrib><title>Augmentation of central arterial pressure in mild primary hyperparathyroidism</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description><![CDATA[Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular risk, although the mechanisms involved remain unclear. Recent evidence has shown increased pulse pressure to be a powerful predictor of cardiovascular events. As increases in pulse pressure are due largely to arterial stiffening, we measured arterial stiffness in 21 subjects with PHPT (18 women and 3 men; 46-71 yr old) and 21 age- and sex-matched healthy controls using pulse wave analysis, a technique that measures peripheral arterial pressure waveforms and generates corresponding central aortic waveforms. This allows determination of the augmentation of central pressure resulting from wave reflection and augmentation index, a measure of vessel stiffness. Metabolic parameters were also measured. The serum calcium level among PHPT subjects was (mean +/- SD) 2.74+/-0.14 mmol/L. pulse wave analysis showed that both augmentation and the augmentation index were significantly higher in the PHPT group vs. controls [16+/-5 vs. 10+/-4 mm Hg (P < 0.001) and 36+/-9% vs. 25+/-6% (P < 0.001)] despite comparable brachial systolic pressures between groups (136+/-13 vs. 134+/-18 mm Hg). Patients with PHPT had higher fasting serum insulin levels [median (range), 15.8 (7.4-39.4) vs. 11.6 (5.1-23) mU/L; P < 0.05] and triglyceride (1.6+/-0.6 vs. 1.2+/-0.4 mmol/L; P < 0.05), but lower high density lipoprotein cholesterol (1.4+/-0.4 vs. 1.6+/-0.3 mmol/L; P < 0.05). These data indicate that subjects with mild PHPT (calcium, <3.0 mmol/L) have increased arterial stiffness, as evidenced by higher augmentation of central aortic pressures. Enhanced vessel stiffness may arise from a combination of structural and functional vascular changes due to hypercalcemia and/or metabolic abnormalities. Increased vascular stiffness in subjects with PHPT may account in part for the increased cardiovascular risk in this group.]]></description><subject>Aged</subject><subject>Aging - physiology</subject><subject>Arteries - pathology</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Blood Pressure - physiology</subject><subject>Calcium - blood</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperparathyroidism - pathology</subject><subject>Hyperparathyroidism - physiopathology</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Parathyroid Hormone - blood</subject><subject>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</subject><subject>Risk Factors</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpF0EtLxDAQB_AgiruuHr1KD-KtayaPJjkuiy9Y8aLgraR5uFn6MmkP--0tWPE08x9-DMMgdA14DQTw_cGsJV9PiXLgJ2gJivFcgBKnaIkxgVwJ8rlAFykdMAbGOD1HCwBcAFN0iV4341fj2kEPoWuzzmdmClHXmY6Di2Fq-uhSGqPLQps1obbTIDQ6HrP9sXex11EP-2Psgg2puURnXtfJXc11hT4eH963z_nu7ellu9nlhnAYcmWN4A5TKLyShS6k8AxLS63gkgJWIImwXlHhK4dNhXkFlSaFBuYM9o7SFbr73dvH7nt0aSibkIyra926bkylIFQSVsAEb2Y4Vo2z5Xx7-feACdzOQCejax91a0L6d5wUUgH9AZpdalo</recordid><startdate>20001001</startdate><enddate>20001001</enddate><creator>SMITH, J. C</creator><creator>PAGE, M. D</creator><creator>JOHN, R</creator><creator>WHEELER, M. H</creator><creator>COCKCROFT, J. R</creator><creator>SCANLON, M. F</creator><creator>DAVIES, J. S</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20001001</creationdate><title>Augmentation of central arterial pressure in mild primary hyperparathyroidism</title><author>SMITH, J. C ; PAGE, M. D ; JOHN, R ; WHEELER, M. H ; COCKCROFT, J. R ; SCANLON, M. F ; DAVIES, J. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c251t-9dc75e0316f986a687f408d3d75831091827df937fbe0cb05b1ba26a14ec0fe33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Aged</topic><topic>Aging - physiology</topic><topic>Arteries - pathology</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Blood Pressure - physiology</topic><topic>Calcium - blood</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperparathyroidism - pathology</topic><topic>Hyperparathyroidism - physiopathology</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Parathyroid Hormone - blood</topic><topic>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SMITH, J. C</creatorcontrib><creatorcontrib>PAGE, M. D</creatorcontrib><creatorcontrib>JOHN, R</creatorcontrib><creatorcontrib>WHEELER, M. H</creatorcontrib><creatorcontrib>COCKCROFT, J. R</creatorcontrib><creatorcontrib>SCANLON, M. F</creatorcontrib><creatorcontrib>DAVIES, J. S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SMITH, J. C</au><au>PAGE, M. D</au><au>JOHN, R</au><au>WHEELER, M. H</au><au>COCKCROFT, J. R</au><au>SCANLON, M. F</au><au>DAVIES, J. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Augmentation of central arterial pressure in mild primary hyperparathyroidism</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2000-10-01</date><risdate>2000</risdate><volume>85</volume><issue>10</issue><spage>3515</spage><epage>3519</epage><pages>3515-3519</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract><![CDATA[Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular risk, although the mechanisms involved remain unclear. Recent evidence has shown increased pulse pressure to be a powerful predictor of cardiovascular events. As increases in pulse pressure are due largely to arterial stiffening, we measured arterial stiffness in 21 subjects with PHPT (18 women and 3 men; 46-71 yr old) and 21 age- and sex-matched healthy controls using pulse wave analysis, a technique that measures peripheral arterial pressure waveforms and generates corresponding central aortic waveforms. This allows determination of the augmentation of central pressure resulting from wave reflection and augmentation index, a measure of vessel stiffness. Metabolic parameters were also measured. The serum calcium level among PHPT subjects was (mean +/- SD) 2.74+/-0.14 mmol/L. pulse wave analysis showed that both augmentation and the augmentation index were significantly higher in the PHPT group vs. controls [16+/-5 vs. 10+/-4 mm Hg (P < 0.001) and 36+/-9% vs. 25+/-6% (P < 0.001)] despite comparable brachial systolic pressures between groups (136+/-13 vs. 134+/-18 mm Hg). Patients with PHPT had higher fasting serum insulin levels [median (range), 15.8 (7.4-39.4) vs. 11.6 (5.1-23) mU/L; P < 0.05] and triglyceride (1.6+/-0.6 vs. 1.2+/-0.4 mmol/L; P < 0.05), but lower high density lipoprotein cholesterol (1.4+/-0.4 vs. 1.6+/-0.3 mmol/L; P < 0.05). These data indicate that subjects with mild PHPT (calcium, <3.0 mmol/L) have increased arterial stiffness, as evidenced by higher augmentation of central aortic pressures. Enhanced vessel stiffness may arise from a combination of structural and functional vascular changes due to hypercalcemia and/or metabolic abnormalities. Increased vascular stiffness in subjects with PHPT may account in part for the increased cardiovascular risk in this group.]]></abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>11061493</pmid><doi>10.1210/jc.85.10.3515</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 2000-10, Vol.85 (10), p.3515-3519
issn 0021-972X
1945-7197
language eng
recordid cdi_proquest_miscellaneous_72382461
source Oxford Journals Online
subjects Aged
Aging - physiology
Arteries - pathology
Biological and medical sciences
Blood Glucose - metabolism
Blood Pressure - physiology
Calcium - blood
Endocrinopathies
Female
Humans
Hyperparathyroidism - pathology
Hyperparathyroidism - physiopathology
Lipids - blood
Male
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Parathyroid Hormone - blood
Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)
Risk Factors
title Augmentation of central arterial pressure in mild primary hyperparathyroidism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A59%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Augmentation%20of%20central%20arterial%20pressure%20in%20mild%20primary%20hyperparathyroidism&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=SMITH,%20J.%20C&rft.date=2000-10-01&rft.volume=85&rft.issue=10&rft.spage=3515&rft.epage=3519&rft.pages=3515-3519&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.85.10.3515&rft_dat=%3Cproquest_pubme%3E72382461%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c251t-9dc75e0316f986a687f408d3d75831091827df937fbe0cb05b1ba26a14ec0fe33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72382461&rft_id=info:pmid/11061493&rfr_iscdi=true